Industry Trend Analysis - Core Growth Drivers Deliver Impressive Sales Returns For Bayer - 22 MAY 2017
Corporate Financing week May 2017 / Germany / Industry
Bayer's better-than-expected Q117 financial results bode well for the company's outlook for 2017. Growth was largely driven by consistently strong business developments within the pharmaceuticals...
Industry Trend Analysis - Slowdown In Pharmaceutical Sales To Be Offset By Actelion Acquisition - 01 MAY 2017
Corporate Financing week April 2017 / United States / Industry
Johnson & Johnson's pharmaceutical business continues to dominate the firm's income statements; however, first quarter results for 2017 have highlighted the increasing challenges it will...
Industry Trend Analysis - Acquisition Bids Highlight Strength Of Stada's Business - 13 MAR 2017
Corporate Financing week March 2017 / Germany / Industry
Potential interest in acquiring Stada Arzneimittel has been building for almost a year, and has now come into the open with these three initial bids. Interest from other firms is certainly a possib...
Industry Trend Analysis - Azaya Acquisition Will Benefit Cytori's Cell Therapy Pipeline - 06 MAR 2017
Corporate Financing week March 2017 / United States / Industry
Cytori's acquisition of Azaya Therapeutics will provide the company with a nanoparticle platform that it can apply to its current pipeline to aid in delivery. The two near-to-market oncology compou...
Industry Trend Analysis - Privatisation Of Local Drugmakers To Enhance Their Competitive Position - 01 AUG 2016
Corporate Financing week July 2016 / Vietnam / Industry
Vietnam's domestic pharmaceutical companies will present a growing competitive threat to multinational firms operating in the South East Asian country. This has been accentuated as the authorities...
Industry Trend Analysis - Medivation Trying To Ignite Bidding War - 25 JULY 2016
Corporate Financing week July 2016 / United States / Industry
A bidding war will likely ensue after Medivation has essentially put itself up for sale. Sanofi could eventually conquer Medivation, but a challenge from Pfizer is probable. Xtandi appears to be...
Industry Trend Analysis - Sagent Acquisition A Logical Next Step For Nichi-Iko - 25 JULY 2016
Corporate Financing week July 2016 / Japan / Industry
Nichi-Iko Pharmaceutical's attention on the US market is a reminder that the US remains by far the largest market in the world for both originator and generic pharmaceuticals. Whilst Japan is the...
Industry Trend Analysis - Lupin On Course To Cement Place In US Market - 14 MAR 2016
Corporate Financing week March 2016 / India / Industry
US FTC consent for Lupin's proposed acquisition of Gavis Pharmaceuticals brings the acquisition a step closer to completion, and with only two products to be divested, the acquisition will be a...
Industry Trend Analysis - Hikma On Track To Boost US Generic Injectables Presence - 07 MAR 2016
Corporate Financing week March 2016 / United States / Industry
Despite the divestitures required by the FTC, Hikma's ongoing acquisition of what was essentially Boehringer Ingelheim's entire generics business will serve to substantially increase Hikma's positi...
Industry Trend Analysis - Expansion Into Asian Emerging Markets To Prove Lucrative - 01 FEB 2016
Corporate Financing week January 2016 / Hungary / Industry
Gedeon Richter's expansion into emerging markets will mitigate any potential risks of loss of sales in the precarious CIS market. It has one of the most extensive gynaecological drug portfolios and...